Legal
Key facts
PR Newswire notice about a securities class action involving ARS Pharmaceuticals Inc. (NASDAQ: SPRY)
Key facts
Eric Karas, ARS Pharmaceuticals’ Chief Commercial Officer, is named as an individual defendant
Key facts
The class action is brought on behalf of purchasers of SPRY securities between March 9, 2026…
Atlas Watchline
A PR Newswire notice says investors in ARS Pharmaceuticals may seek lead-plaintiff status in a securities…